I still think China is the main opportunity. But as you say, diversifying into other markets is important for A2M in order to sustain its growth for longer. USA is the #1 candidate in terms of other potential markets.
When it comes to China, Bortolussi pointed out at last years AGM that needs to look a lot more like the other top 10 IMF competitors, Feihe, China Mengniu, Danone etc. in certain areas if it wants to grow its share further. For instance, all the other companies in the top 10 own their own manufacturing and SAMR licences, most with multiple licences allowing them greater product differentiation etc.
I guess another part of moving into the bigger league is being able to focus on more than one market at once.
BUB's many woes are pretty complicated and can't be directly attributed to getting into the USA business. It is more to do with the catastrophic failure of its China business. This has probably been compounded by doubling down on USA and failing to address their China issues. But the irony is the USA revenues are pretty much the only thing keeping them afloat.
- Forums
- ASX - By Stock
- A2M
- Media Updates
Media Updates, page-13800
-
-
- There are more pages in this discussion • 621 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.64 |
Change
-0.110(1.63%) |
Mkt cap ! $4.800B |
Open | High | Low | Value | Volume |
$6.73 | $6.73 | $6.59 | $9.976M | 1.499M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 37684 | $6.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.65 | 1001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 11925 | 6.610 |
6 | 80683 | 6.600 |
6 | 12930 | 6.590 |
4 | 26202 | 6.580 |
1 | 1531 | 6.530 |
Price($) | Vol. | No. |
---|---|---|
6.650 | 1001 | 1 |
6.660 | 13410 | 3 |
6.670 | 28169 | 2 |
6.680 | 8169 | 1 |
6.690 | 21645 | 2 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online